Prokidney (PROK) Consolidated Net Income (2022 - 2025)

Prokidney (PROK) has disclosed Consolidated Net Income for 4 consecutive years, with -$35.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Consolidated Net Income rose 18.69% to -$35.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$155.5 million, a 14.34% decrease, with the full-year FY2024 number at -$163.3 million, down 20.59% from a year prior.
  • Consolidated Net Income was -$35.3 million for Q3 2025 at Prokidney, up from -$36.1 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of -$18.9 million in Q4 2023 to a low of -$66.5 million in Q1 2022.
  • A 4-year average of -$36.6 million and a median of -$36.1 million in 2025 define the central range for Consolidated Net Income.
  • Peak YoY movement for Consolidated Net Income: skyrocketed 44.48% in 2023, then plummeted 147.09% in 2024.
  • Prokidney's Consolidated Net Income stood at -$24.4 million in 2022, then grew by 22.48% to -$18.9 million in 2023, then tumbled by 147.09% to -$46.8 million in 2024, then increased by 24.58% to -$35.3 million in 2025.
  • Per Business Quant, the three most recent readings for PROK's Consolidated Net Income are -$35.3 million (Q3 2025), -$36.1 million (Q2 2025), and -$37.4 million (Q1 2025).